128 related articles for article (PubMed ID: 9260278)
21. Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41.
Chen SS; Lee SF; Wang CT
J Virol; 2001 Oct; 75(20):9925-38. PubMed ID: 11559825
[TBL] [Abstract][Full Text] [Related]
22. Conserved residues in the coiled-coil pocket of human immunodeficiency virus type 1 gp41 are essential for viral replication and interhelical interaction.
Mo H; Konstantinidis AK; Stewart KD; Dekhtyar T; Ng T; Swift K; Matayoshi ED; Kati W; Kohlbrenner W; Molla A
Virology; 2004 Nov; 329(2):319-27. PubMed ID: 15518811
[TBL] [Abstract][Full Text] [Related]
23. Protein design of a bacterially expressed HIV-1 gp41 fusion inhibitor.
Deng Y; Zheng Q; Ketas TJ; Moore JP; Lu M
Biochemistry; 2007 Apr; 46(14):4360-9. PubMed ID: 17371053
[TBL] [Abstract][Full Text] [Related]
24. The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors.
Gallo SA; Sackett K; Rawat SS; Shai Y; Blumenthal R
J Mol Biol; 2004 Jun; 340(1):9-14. PubMed ID: 15184018
[TBL] [Abstract][Full Text] [Related]
25. Human immunodeficiency virus (HIV) gp41 escape mutants: cross-resistance to peptide inhibitors of HIV fusion and altered receptor activation of gp120.
Desmezieres E; Gupta N; Vassell R; He Y; Peden K; Sirota L; Yang Z; Wingfield P; Weiss CD
J Virol; 2005 Apr; 79(8):4774-81. PubMed ID: 15795263
[TBL] [Abstract][Full Text] [Related]
26. [Expression of recombinant HIV-1 envelope glycoprotein gp41].
Teng Z; Li D; Gao L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Jun; 13(2):113-6. PubMed ID: 12569773
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of human immunodeficiency virus type 1 Gag expression by a gp41 cytoplasmic domain fusion protein.
Chan WE; Chen SS
Virology; 2006 May; 348(2):418-29. PubMed ID: 16472834
[TBL] [Abstract][Full Text] [Related]
28. The cytoplasmic domain of HIV-1 gp41 interacts with the carboxyl-terminal region of alpha-catenin.
Kim EM; Lee KH; Kim JW
Mol Cells; 1999 Jun; 9(3):281-5. PubMed ID: 10420987
[TBL] [Abstract][Full Text] [Related]
29. An efficient production and characterization of HIV-1 gp41 ectodomain with fusion peptide in Escherichia coli system.
Lin CH; Lin CH; Chang CC; Wei TS; Cheng SF; Chen SS; Chang DK
J Biotechnol; 2011 Apr; 153(1-2):48-55. PubMed ID: 21419812
[TBL] [Abstract][Full Text] [Related]
30. Assembly of a rod-shaped chimera of a trimeric GCN4 zipper and the HIV-1 gp41 ectodomain expressed in Escherichia coli.
Weissenhorn W; Calder LJ; Dessen A; Laue T; Skehel JJ; Wiley DC
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6065-9. PubMed ID: 9177169
[TBL] [Abstract][Full Text] [Related]
31. Structural and functional analysis of the HIV gp41 core containing an Ile573 to Thr substitution: implications for membrane fusion.
Liu J; Shu W; Fagan MB; Nunberg JH; Lu M
Biochemistry; 2001 Mar; 40(9):2797-807. PubMed ID: 11258890
[TBL] [Abstract][Full Text] [Related]
32. Production, purification, and crystallization of human interleukin-1 beta converting enzyme derived from an Escherichia coli expression system.
Malinowski JJ; Grasberger BL; Trakshel G; Huston EE; Helaszek CT; Smallwood AM; Ator MA; Banks TM; Brake PG; Ciccarelli RB
Protein Sci; 1995 Oct; 4(10):2149-55. PubMed ID: 8535252
[TBL] [Abstract][Full Text] [Related]
33. Oligomerization of the hydrophobic heptad repeat of gp41.
Bernstein HB; Tucker SP; Kar SR; McPherson SA; McPherson DT; Dubay JW; Lebowitz J; Compans RW; Hunter E
J Virol; 1995 May; 69(5):2745-50. PubMed ID: 7707497
[TBL] [Abstract][Full Text] [Related]
34. Core structure of gp41 from the HIV envelope glycoprotein.
Chan DC; Fass D; Berger JM; Kim PS
Cell; 1997 Apr; 89(2):263-73. PubMed ID: 9108481
[TBL] [Abstract][Full Text] [Related]
35. Multimerization potential of the cytoplasmic domain of the human immunodeficiency virus type 1 transmembrane glycoprotein gp41.
Lee SF; Wang CT; Liang JY; Hong SL; Huang CC; Chen SS
J Biol Chem; 2000 May; 275(21):15809-19. PubMed ID: 10747937
[TBL] [Abstract][Full Text] [Related]
36. Single-chain protein mimetics of the N-terminal heptad-repeat region of gp41 with potential as anti-HIV-1 drugs.
Crespillo S; Cámara-Artigas A; Casares S; Morel B; Cobos ES; Mateo PL; Mouz N; Martin CE; Roger MG; El Habib R; Su B; Moog C; Conejero-Lara F
Proc Natl Acad Sci U S A; 2014 Dec; 111(51):18207-12. PubMed ID: 25489108
[TBL] [Abstract][Full Text] [Related]
37. Solid-state nuclear magnetic resonance (NMR) spectroscopy of human immunodeficiency virus gp41 protein that includes the fusion peptide: NMR detection of recombinant Fgp41 in inclusion bodies in whole bacterial cells and structural characterization of purified and membrane-associated Fgp41.
Vogel EP; Curtis-Fisk J; Young KM; Weliky DP
Biochemistry; 2011 Nov; 50(46):10013-26. PubMed ID: 21985645
[TBL] [Abstract][Full Text] [Related]
38. Interfacial properties and structure stability of the gp41 tryptophan-rich peptide from HIV-1.
Matar G; Nasir MN; Besson F
J Colloid Interface Sci; 2010 Dec; 352(2):520-5. PubMed ID: 20850757
[TBL] [Abstract][Full Text] [Related]
39. Structural and functional analysis of interhelical interactions in the human immunodeficiency virus type 1 gp41 envelope glycoprotein by alanine-scanning mutagenesis.
Lu M; Stoller MO; Wang S; Liu J; Fagan MB; Nunberg JH
J Virol; 2001 Nov; 75(22):11146-56. PubMed ID: 11602754
[TBL] [Abstract][Full Text] [Related]
40. Biophysical characterization of recombinant proteins expressing the leucine zipper-like domain of the human immunodeficiency virus type 1 transmembrane protein gp41.
Shugars DC; Wild CT; Greenwell TK; Matthews TJ
J Virol; 1996 May; 70(5):2982-91. PubMed ID: 8627774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
